2020 ASCO Virtual Direct™ Highlights


 

2020 ASCO Highlights on Melanoma: Dabrafenib + Trametinib in Patients With Resected Stage III BRAF V600-Mutant Melanoma - Is There a Long-Term Survival Benefit?

59 views
September 13, 2020
0 Comments
Login to view comments. Click here to Login